NasdaqCM - Nasdaq Real Time Price USD
BioLife Solutions, Inc. (BLFS)
21.89
+0.74
+(3.50%)
At close: April 22 at 4:00:02 PM EDT
22.33
+0.44
+(2.01%)
Pre-Market: 7:21:28 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.04 | -0.01 | -0.03 | 0.15 |
| Low Estimate | -0.05 | -0.02 | -0.07 | 0.1 |
| High Estimate | -0.02 | -0.01 | 0 | 0.18 |
| Year Ago EPS | -0.2 | -0.05 | -0.06 | -0.03 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 7 |
| Avg. Estimate | 22.22M | 23.46M | 97.03M | 116.41M |
| Low Estimate | 20.3M | 22.9M | 95.5M | 112M |
| High Estimate | 25.95M | 24M | 98M | 121.6M |
| Year Ago Sales | 31.73M | 28.33M | 82.25M | 97.03M |
| Sales Growth (year/est) | -29.96% | -17.19% | 17.96% | 19.98% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.2 | -0.09 | -0.05 | -0.06 |
| EPS Actual | -0.2 | -0.05 | -0.02 | -0.02 |
| Difference | -0 | 0.04 | 0.03 | 0.04 |
| Surprise % | -0.05% | 45.68% | 62.50% | 71.77% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.04 | -0.01 | -0.03 | 0.15 |
| 7 Days Ago | -0.04 | -0.01 | -0.03 | 0.15 |
| 30 Days Ago | -0.04 | -0.01 | -0.03 | 0.15 |
| 60 Days Ago | -0.04 | -0.03 | 0.01 | 0.28 |
| 90 Days Ago | -0.03 | -0.01 | 0 | 0.34 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 3 | 1 |
| Up Last 30 Days | 1 | 2 | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLFS | 82.33% | 70.41% | 53.56% | 588.90% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/6/2025 |
| Maintains | Northland Capital Markets: Outperform to Outperform | 1/8/2025 |
| Reiterates | Benchmark: Buy to Buy | 12/19/2024 |
| Maintains | Keybanc: Overweight to Overweight | 12/13/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/18/2024 |
| Maintains | TD Cowen: Buy to Buy | 11/13/2024 |
Related Tickers
BLFE BioLife Sciences Inc.
0.0001
0.00%
AVR Anteris Technologies Global Corp.
3.5100
+11.78%
ATRC AtriCure, Inc.
31.97
+0.72%
MMSI Merit Medical Systems, Inc.
91.45
+2.06%
HBIO Harvard Bioscience, Inc.
0.3933
+7.99%
ANGO AngioDynamics, Inc.
9.30
+0.54%
WST West Pharmaceutical Services, Inc.
215.13
+4.49%
BLCO Bausch + Lomb Corporation
12.49
+3.65%
RGEN Repligen Corporation
138.93
+5.54%
RMD ResMed Inc.
214.08
+1.52%